Holen Sie sich die Stockscreener-App
14.45
1.55%
0.22
Handel nachbörslich:
14.45
Schlusskurs vom Vortag:
$14.23
Offen:
$14.5
24-Stunden-Volumen:
1.35M
Relative Volume:
0.98
Marktkapitalisierung:
$887.59M
Einnahmen:
$492.05M
Nettoeinkommen (Verlust:
$197.92M
KGV:
6.2826
EPS:
2.3
Netto-Cashflow:
$176.12M
1W Leistung:
-0.82%
1M Leistung:
-6.53%
6M Leistung:
-25.55%
1J Leistung:
-21.30%
1-Tages-Spanne:
$14.34
$14.78
1-Wochen-Bereich:
$14.01
$14.82
52-Wochen-Spanne:
$13.68
$19.85
Inmode Ltd Stock (INMD) Company Profile
Vergleichen Sie INMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.45 | 887.59M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
Shareholders that lost money on InMode Ltd. (INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
DOMA Perpetual urges InMode to replace CEO, resume buybacks By Investing.com - Investing.com South Africa
DOMA Perpetual urges InMode to replace CEO, resume buybacks - Investing.com Australia
InMode Shareholder DOMA Perpetual Seeks CEO Ouster, Buyback Resumption - marketscreener.com
Doma Perpetual Sends Letter To The Board Of Inmode To Resume Share Repurchase Program - marketscreener.com
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program - PR Newswire
Shareholders that lost money on InMode Ltd.(INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
InMode Ltd. has secured a significant legal victory against counterfeit sellers of its Morpheus8 devices, reinforcing its commitment to consumer safety and intellectual property protection. - medianet.com.au
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode to Present at Upcoming Investor Conferences and Events - Stock Titan
InMode (INMD) Wins Legal Battle Against Counterfeit Sellers - GuruFocus
We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings - Yahoo Finance
InMode Granted Injunction Against Counterfeit Sellers of Morpheus8 Products - marketscreener.com
InMode (INMD) Secures Legal Victory Against Counterfeiters | INM - GuruFocus
InMode wins court case against counterfeit sellers - Investing.com Australia
InMode wins court case against counterfeit sellers By Investing.com - Investing.com South Africa
Court Orders Shutdown of Counterfeit Morpheus8 Sellers: How to Verify Your Provider's Authenticity - Stock Titan
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M - Seeking Alpha
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth - Seeking Alpha
(INMD) Trading Signals - news.stocktradersdaily.com
Canaccord cuts InMode stock target to $15, maintains hold rating By Investing.com - Investing.com South Africa
InMode Ltd. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
InMode Reports Q1 2025 Financial Results Amid Challenges - TipRanks
Canaccord cuts InMode stock target to $15, maintains hold rating - Investing.com
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concern - GuruFocus
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concerns | INMD Stock News - GuruFocus
UBS Adjusts InMode Price Target to $16.25 From $19, Maintains Neutral Rating - marketscreener.com
InMode (INMD) Price Target Reduced by UBS Amid Uncertain Near-Te - GuruFocus
BTIG cuts InMode stock rating amid challenging market By Investing.com - Investing.com Nigeria
BTIG cuts InMode stock rating amid challenging market - Investing.com
InMode Ltd. (NASDAQ:INMD) Q1 2025 Earnings Call Transcript - Insider Monkey
InMode (INMD) Price Target Reduced Amid Ongoing Challenges | INM - GuruFocus
BTIG Research Downgrades InMode to Neutral From Buy - marketscreener.com
InMode (INMD) Faces Downgrade Amid Challenging Market Conditions - GuruFocus
InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (NASDAQ:INMD) - Seeking Alpha
InMode Shares Dip Over 11% After Earnings Miss Expectations - Finimize
InMode (INMD) Revises Profit Guidance Amid Economic Hurdles - GuruFocus
InMode revenue decreases 3% to USD 77.9 million in Q1 2025 - Medical Buyer
InMode Ltd (INMD) Shares Gap Down to $14.355 on Apr 28 - GuruFocus
InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) - Seeking Alpha
InMode slides on lowered full year profit guidance - MSN
INMD Beats Revenue Expectations, Faces U.S. Market Challenges | - GuruFocus
Baird Downgrades InMode to Neutral From Outperform, $16 Price Target; Shares Fall - marketscreener.com
InMode slides on full year profit guidance cut (INMD:NASDAQ) - Seeking Alpha
InMode: Q1 Earnings Snapshot - The Wilton Bulletin
InMode earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa
InMode Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
InMode Reports First Quarter 2025 Financial Results; Quarterly R - GuruFocus
InMode (INMD) Lags Q1 Earnings Estimates - Yahoo Finance
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):